Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF FEBRUARY 28, 2010 FBO #3018
SOLICITATION NOTICE

A -- Generation, Characterization and Production of Monoclonal Antibody VRC01 - Solicitation Package

Notice Date
2/26/2010
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
325412 — Pharmaceutical Preparation Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bldg 427, Room 12, Frederick, Maryland, 21702
 
ZIP Code
21702
 
Solicitation Number
S10-129
 
Archive Date
3/30/2010
 
Point of Contact
Max R. Moore, Phone: 3012284019
 
E-Mail Address
mooremax@mail.nih.gov
(mooremax@mail.nih.gov)
 
Small Business Set-Aside
N/A
 
Description
S10-129 Attachment 2 is the statement of work. S10-129 Attachment 1 is the sample subcontract agreement. RFP S10-129 includes the instructions to offerors and evaluation criteria. This contract will cover the generation and characterization of a stable CHO cell line expressing the VRC01 MAb and production of bulk materials for preclinical and clinical trial along with the required lot release and stability testing of all clinical materials. This contract will also include formulation development to obtain a drug product formulation that is suitable for the proposed clinical trials. Additionally, this contract includes QA and regulatory support for lot release and filing of all regulatory documents with the FDA for VRC sponsored INDs.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/FCRF/S10-129/listing.html)
 
Record
SN02077814-W 20100228/100226235528-ccf78aee55c35e501085660ee6161c91 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.